Teradyne Plans $300 Million FormFactor Investment, Far Larger Than Prior Advantest Pact
Teradyne agreed to make a $300 million equity investment in FormFactor, linking its automated chip testers with FormFactor's probing and measurement technology. The proposed amount is about 20 times larger than FormFactor's January 2025 technology partnership and share purchase agreement with Advantest, valued at roughly $15 million. The deal still requires customary conditions and regulatory approvals, and it does not establish new sales, guaranteed demand, or immediate earnings growth.
... Need plain text. No markdown? Labeled sections. Fine. Need ensure EXPANDED drawn only from material above. We used "Teradyne agreed to buy $300 million of FormFactor equity" from material. "the companies said after U.S. markets closed Monday, Oct. 12" yes. "The plan links..." yes. "Their targets include..." yes. "testing tools meant to work together across systems" derived from open interoperable ecosystem. "Closing depends on standard conditions and regulatory clearances" from customary conditions and regulatory approvals. "That follows FormFactor’s January 2025 partnership and share purchase with Advantest, valued near $15 million." yes. "The earlier pact covered roughly 335,000 shares at $44.78 each." yes. "Teradyne’s proposed amount is about 20 times larger." yes. "The announcement left out per-share price, share count, ownership percentage, closing date and customer-revenue commitments, so it does not guarantee sales or immediate earnings growth." yes. Good. Potential issue: